Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects

Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects

Palmitoylethanolamide (PEA) is an endogenous lipid produced on demand by neurons and glial cells that displays neuroprotective properties. It is well known that inflammation and neuronal damage are strictly related processes and that microglia play a pivotal role in their regulation. The aim of the...

Full description

Bibliographic Details
Main Authors:	Alessia D’Aloia, Laura Molteni, Francesca Gullo, Elena Bresciani, Valentina Artusa, Laura Rizzi, Michela Ceriani, Ramona Meanti, Marzia Lecchi, Silvia Coco, Barbara Costa, Antonio Torsello
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	International Journal of Molecular Sciences
Subjects:	palmitoylethanolamide microglia morphotypes neuroinflammation cytokines cannabinoid receptor
Online Access:	https://www.mdpi.com/1422-0067/22/6/3054

Similar Items

Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide
by: Alessia D’Aloia, et al.
Published: (2020-11-01)

Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia
by: Urszula Hohmann, et al.
Published: (2019-11-01)

Pharmacology of Palmitoylethanolamide and Related Compounds
by: Jonsson, Kent-Olov
Published: (2005)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01)

Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
by: Alessio Filippo Peritore, et al.
Published: (2019-09-01)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019-08-01)

Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
by: Alessio Filippo Peritore, et al.
Published: (2021-05-01)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018-03-01)

Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache
by: Chirchiglia D, et al.
Published: (2016-07-01)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
by: Rosalba Siracusa, et al.
Published: (2020-10-01)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
by: Amanda Rao, et al.
Published: (2021-09-01)

Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy
by: Julia M. Post, et al.
Published: (2018-03-01)

Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
by: Lucas D. Udovin, et al.
Published: (2020-01-01)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
by: Alshelh Z, et al.
Published: (2019-08-01)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
by: Chirchiglia D, et al.
Published: (2019-02-01)

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
by: Scuderi Caterina, et al.
Published: (2012-03-01)

Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat
by: Alessio Filippo Peritore, et al.
Published: (2020-05-01)

Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study
by: Jordi Faig-Martí, et al.
Published: (2017-03-01)

Therapeutic benefit of palmitoylethanolamide in the management of neuropathic pain
by: I. D. Chaurasia, et al.
Published: (2018-12-01)

Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
by: Rosanna Di Paola, et al.
Published: (2016-10-01)

Short-term efficacy of a fixed association of Palmitoylethanolamide and other phytochemicals as add-on therapy in the management of chronic pain in elderly patients: a real-world retrospective study
by: Walter Gianni, et al.
Published: (2018-05-01)

Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury
by: Rosalia eCrupi, et al.
Published: (2016-03-01)

Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
by: Maria Beatrice Passavanti, et al.
Published: (2019-01-01)

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
by: Stefania Petrosino, et al.
Published: (2019-12-01)

Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse
by: Fiorentina Roviezzo, et al.
Published: (2017-12-01)

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
by: Giorgia della Rocca, et al.
Published: (2021-03-01)

Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing
by: Enrico Gugliandolo, et al.
Published: (2020-06-01)

Microglia and mast cells: new targets for the treatment of chronic pain
by: V.I. Romanenko
Published: (2021-06-01)

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery
by: Carmelo Puglia, et al.
Published: (2018-03-01)

Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain
by: María I. Herrera, et al.
Published: (2018-03-01)

The endocannabinoid system is modulated in response to spinal cord injury in rats
by: Daniel Garcia-Ovejero, et al.
Published: (2009-01-01)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
by: Enrico Gugliandolo, et al.
Published: (2020-08-01)

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models
by: Domenico Britti, et al.
Published: (2017-08-01)

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
by: Dong-Soon Im
Published: (2021-01-01)

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries. A Systematic Review
by: Stefania Petrosino, et al.
Published: (2020-12-01)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D’Amico, et al.
Published: (2021-06-01)

Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile
by: Carmelo Puglia, et al.
Published: (2020-02-01)

Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease
by: Vanessa D’Antongiovanni, et al.
Published: (2021-09-01)